Pacira BioSciences (PCRX) Proxy filing summary

Executive summary

• Press release addresses misleading statements by DOMA regarding intellectual property strategy and urges stockholders to vote for the board’s nominees on the BLUE proxy card.

• Highlights the strength and expansion of the EXPAREL patent estate, including recent litigation outcomes and new patent issuances.

• Emphasizes ongoing execution of a five-year growth strategy and continued focus on maximizing stockholder value.

• Outlines forward-looking statements regarding business outlook, product pipeline, and strategic initiatives.

Voting matters and shareholder proposals

• Stockholders are urged to vote “FOR” the election of three highly qualified board nominees and to disregard any proxy card from DOMA.

• Proxy solicitation materials and voting instructions are provided, with contact information for assistance.

Board of directors and corporate governance

• Information about director nominees and their interests is available in the definitive proxy statement and supplemental filings.

• Details on board composition and governance practices are referenced in the proxy statement.